Top Markets
#1 Black Phoenix Black Phoenix +829.08%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.93%
#3 Beam Beam +23.05%
#4 SAFEcoin SAFEcoin +20.65%
#5 Not in Employment, Education, or Training Not in Employment, Education, or Training +19.20%
#6 Magma Finance Magma Finance +16.99%
#7 Prom Prom +16.39%
#8 Bless Bless +16.28%
#9 Wrapped STX (Velar) Wrapped STX (Velar) +16.00%
#10 THORChain THORChain +15.86%
Coin of the day
Black Phoenix Black Phoenix
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Alamar Biosciences, Inc. Alamar Biosciences, Inc.

Alamar Biosciences, Inc.

ALMR
Clasificación en acciones #5889
Alamar Biosciences operates as a commercial-stage proteomics firm, specializing... Alamar Biosciences operates as a commercial-stage proteomics firm, specializing in the highly sensitive, simultaneous identification of various proteins for both scientific research and prospective medical applications. Their integrated platform brings together proprietary instruments, specialized consumables, and unique software, forming a comprehensive, end-to-end solution. This system is designed for accurately quantifying multiple proteins, particularly those present in low concentrations, across a wide array of research and potential clinical uses.
Precio por acción
$34.56
Capitalización bursátil
$2.40B
Cambio (1 día)
1.41%
Cambio (1 año)
-
País
US
Comercio Alamar Biosciences, Inc. (ALMR)

Categoría

Healthcare
Ganancias de Alamar Biosciences, Inc. (ALMR)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Alamar Biosciences, Inc., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Alamar Biosciences, Inc. desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH